论文部分内容阅读
我们试制的消炎痛混悬液,经我院眼科做了一系列的动物试验、病理组织学检查并经临床初步试用,对减轻炎症和病理反应,抑制角膜新生血管等有较好的作用。(1) 现将0.5%消炎痛混悬液的配方、制备程序和初步体会报告如下:
Our trial of indomethacin suspension, our hospital ophthalmology done a series of animal experiments, histopathological examination and preliminary clinical trial, to reduce inflammation and pathological response, inhibition of corneal neovascularization and so have a better effect. (1) Now 0.5% indomethacin suspension formulations, preparation procedures and preliminary experience report as follows: